Bio Green Med Solution, Inc.

NASDAQ: BGMS · Healthcare · Medical - Pharmaceuticals

PublicHQ Kuala Lumpur, CIK 0001130166Reports USD

#890 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

47D

FH 46DQ 54GM —SS 23

v0.1 · 55/100 weight · provisional

↑ revenue growth (YoY), balance-sheet leverage · ↓ listing tenure, Altman-Z

Methodology →

Revenue TTM

$1.5M

Rev growth YoY (TTM)

+10792.9%

Net income (FY)

-$3.0M

Employees

Market cap

$2.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$747.0k$747.0k2025

Net income-$3.0M-$3.0M2025

Operating income-$8.4M-$8.4M2025

Total assets$8.2M$8.2M2025

Liabilities$1.3M$1.3M2025

Equity$6.8M$6.8M2025

Revenue trend

FY2018 – FY2025 · USD

FY18

$150.0k

FY18

FY21

FY22

$420.0k

FY23

$43.0k

FY24

$747.0k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Bio Green Med Solution, Inc. booked $747.0k in FY2025 revenue, growing 1637% year over year — faster than 97% of Healthcare companies we track, at a -401.3% net margin.

Peers · Healthcare

Telo Genomics Corp.——Digital Commodities Inc.52D VitaSpring Biomedical Co. Ltd.18D 1933 Industries Inc.——

Key facts

CEOSing Ee Wong

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersKuala Lumpur, null

ExchangeNASDAQ: BGMS

Employees12

IPO date2025-09-12

Latest filings

8-K2026-07-01 8-K2026-06-22 8-K2026-06-10 8-K2026-06-04 10-Q2026-05-15 8-K2026-05-14 DEF 14A2026-04-27 8-K2026-04-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.